-
Clinical study for men at high genetic risk for prostate cancer
-
Clinical trial to study if antibiotics can boost immune response in liver cancer
-
A patient’s 10-year journey to moxetumomab for hairy cell leukemia
-
Cyclophosphamide works in an unexpected way to curb graft-vs-host disease in mice
-
iCURE helps a first-generation American reach her goal
-
Dr. Coleman is #NowHiring a postdoctoral fellow specializing in radiation oncology and molecular therapeutics. Lear… https://t.co/usH2cvFSrd
-
#ClinicalTrialsTuesday Now recruiting for a #ClinicalTrial to determine whether antibiotics can boost immune respon… https://t.co/vmDaXRxAtN
-
RT @NIHBrainTumor: Why is it important to understand the impact of treatments on patients? Preliminary data shows that almost all pati… https://t.co/XxHt6xLdX7
-
Phosphatase 1 Nuclear Targeting Subunit, a Novel DNA Repair Partner of PARP1 is the latest #CCRAdvance from Pommier… https://t.co/1r0iEK0URd
-
RT @theNCI: In the Pediatric MATCH trial, 24% of young patients with advanced cancers were found to be eligible to receive one… https://t.co/dGOTTpaJtV
-
Many #Neurofibromatosis patients spend time educating others and raising awareness for the genetic disorder #EndNF… https://t.co/GbbEWMcpNG
-
RT @NCICancerTrials: Dr. Christine Heske, a pediactric oncologist, says, “Kids bring an energy and positive outlook. They are probably t… https://t.co/pwGd3hqdmp
